Among the numerous molecules implicated in the pathophysiology of MASLD is the recently identified hormone asprosin, which serves as the endogenous ligand for the olfactory receptor Olfr734. The gene discussed is OR4M1; the disease is metabolic dysfunction-associated steatotic liver disease.